These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 2973531)
21. The immunogenicity and safety of intradermal hepatitis B vaccine. Toffler WL; Olenick JS; Wolf NE; Retzlaff ZH; Swanson JR; Kenny TA J Fam Pract; 1991 Aug; 33(2):149-54. PubMed ID: 1832438 [TBL] [Abstract][Full Text] [Related]
22. Comparative immunogenicity in children of mammalian cell-derived recombinant hepatitis B vaccine and plasma-derived hepatitis B vaccine. Coursaget P; Bringer L; Sarr G; Bourdil C; Fritzell B; Blondeau C; Yvonnet B; Chiron JP; Jeannée E; Guindo S Vaccine; 1992; 10(6):379-82. PubMed ID: 1534640 [TBL] [Abstract][Full Text] [Related]
23. Intradermal hepatitis B immunization with yeast-derived vaccine: serological response by sex and age. Morris CA; Oliver PR; Reynolds F; Selkon JB Epidemiol Infect; 1989 Oct; 103(2):387-94. PubMed ID: 2530104 [TBL] [Abstract][Full Text] [Related]
24. Relationship of stress, distress, and the immunologic response to a recombinant hepatitis B vaccine. Petry LJ; Weems LB; Livingstone JN J Fam Pract; 1991 May; 32(5):481-6. PubMed ID: 1827147 [TBL] [Abstract][Full Text] [Related]
25. Cost effectiveness of intradermal vs. subcutaneous hepatitis B vaccination for the mentally handicapped. Hayashi J; Nakashima K; Noguchi A; Morofuji M; Kashiwagi S J Infect; 1991 Jul; 23(1):39-45. PubMed ID: 1832182 [TBL] [Abstract][Full Text] [Related]
26. Immunogenicity and efficacy of anti-hepatitis B vaccines in hemodialysis patients. Dentico P; Volpe A; Buongiorno R; Maracchione N; Carbone M; Manno C; Proscia F Nephron; 1992; 61(3):324-5. PubMed ID: 1386904 [TBL] [Abstract][Full Text] [Related]
27. Antibody responses to recombinant, yeast-derived hepatitis B vaccine in teenage New Zealand children. Milne A; Moyes CD; Allwood GK; Pearce NE; Krugman S N Z Med J; 1988 Feb; 101(840):67-9. PubMed ID: 2967940 [TBL] [Abstract][Full Text] [Related]
28. Safety and immunogenicity of a recombinant hepatitis B vaccine in patients infected with Schistosoma mansoni. Bassily S; Hyams KC; el-Ghorab N; el-Masry NA Am J Trop Med Hyg; 1990 May; 42(5):449-52. PubMed ID: 2140243 [TBL] [Abstract][Full Text] [Related]
30. Impaired responsiveness of homosexual men with HIV antibodies to plasma derived hepatitis B vaccine. Carne CA; Weller IV; Waite J; Briggs M; Pearce F; Adler MW; Tedder RS Br Med J (Clin Res Ed); 1987 Apr; 294(6576):866-8. PubMed ID: 3105779 [TBL] [Abstract][Full Text] [Related]
31. Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness. Stephenne J Vaccine; 1988 Aug; 6(4):299-303. PubMed ID: 2973187 [TBL] [Abstract][Full Text] [Related]
32. Prevalence, incidence, and progression of human immunodeficiency virus infection in homosexual and bisexual men in hepatitis B vaccine trials, 1978-1988. Hessol NA; Lifson AR; O'Malley PM; Doll LS; Jaffe HW; Rutherford GW Am J Epidemiol; 1989 Dec; 130(6):1167-75. PubMed ID: 2531543 [TBL] [Abstract][Full Text] [Related]
33. A randomized double-blind clinical trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine compared with a plasma-derived vaccine. Halliday ML; Rankin JG; Bristow NJ; Coates RA; Corey PN; Strickler AC Arch Intern Med; 1990 Jun; 150(6):1195-200. PubMed ID: 2141247 [TBL] [Abstract][Full Text] [Related]
34. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study. Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584 [TBL] [Abstract][Full Text] [Related]
36. Nonresponse to hepatitis B vaccine in homosexual men. Ostrow DG; Goldsmith J; Kalish SB; Chmiel JS; Hadler SC; Phair JP Sex Transm Dis; 1987; 14(2):92-7. PubMed ID: 3649963 [TBL] [Abstract][Full Text] [Related]
37. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study. Sapru A; Kulkarni PS; Bhave S; Bavdekar A; Naik SS; Pandit AN J Trop Pediatr; 2007 Oct; 53(5):303-7. PubMed ID: 17478542 [TBL] [Abstract][Full Text] [Related]
38. Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials. Fabrizi F; Dixit V; Messa P; Martin P Vaccine; 2012 Mar; 30(13):2295-300. PubMed ID: 22285268 [TBL] [Abstract][Full Text] [Related]
39. Immunisation of staff of a regional blood transfusion centre with a recombinant hepatitis B vaccine. Rogan PD; Duguid JK J Infect; 1991 Jan; 22(1):5-9. PubMed ID: 1825836 [TBL] [Abstract][Full Text] [Related]
40. Evolution of acute hepatitis B in homosexual men to chronic hepatitis B. Prospective study of placebo recipients in a hepatitis B vaccine trial. Shah N; Ostrow D; Altman N; Baker AL Arch Intern Med; 1985 May; 145(5):881-2. PubMed ID: 3158291 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]